medic
research
univers
research
institut
industri
today
struggl
promot
translat
researchth
catchphras
bench
bedsid
achiev
basic
biomed
research
potenti
postgenom
era
evid
orat
prais
clinic
research
archibald
garrod
pioneer
clinic
research
past
centuri
greatli
influenc
cambridg
biologist
apostl
mendel
william
bateson
quot
word
counsel
beginn
treasur
except
none
work
get
dull
one
care
carri
keep
alway
uncov
sight
except
like
rough
brickwork
grow
build
tell
come
shew
next
construct
garrod
harveian
orat
entitl
debt
scienc
medicin
debt
scienc
medicin
fact
grown
even
garrod
might
envisag
fuell
debt
recur
theme
recognit
elucid
except
except
investig
except
institut
chosen
exampl
reflect
larg
person
experi
astut
observ
singl
case
small
group
patient
start
point
voyag
scientif
discoveryfrom
bedsid
benchbut
shall
illustr
synergi
clinic
basic
biomed
research
provid
medic
scientist
investig
tool
hitherto
unimagin
power
american
paediatrician
alfr
knudson
fascin
childhood
tumour
retinoblastoma
observ
wherea
sporad
form
almost
invari
unilater
unifoc
present
variou
time
childhood
famili
form
often
bilater
multifoc
present
soon
birth
figur
knudson
deduc
famili
form
inherit
loss
gene
respons
suppress
tumour
format
million
cell
divis
take
place
retinoblast
differenti
chanc
lose
second
copi
gene
suffici
high
make
develop
tumour
like
wherea
two
mutat
would
requir
caus
diseas
nonfamili
case
explain
rariti
later
unifoc
present
knudson
twohit
hypothesi
ignit
field
cancer
genet
herald
era
tumoursuppressor
biolog
knudson
predict
fulfil
rich
period
cancer
research
culmin
clone
retinoblastoma
rb
gene
laboratori
robert
weinberg
year
later
somat
mutat
rb
gene
found
tumour
nonhereditari
case
find
forerunn
observ
well
establish
work
vogelstein
other
patient
common
cancer
often
mutat
gene
respons
famili
form
cancer
recognis
genet
diseas
case
acquir
result
seri
somat
mutat
vital
clue
provid
studi
famili
case
fastforward
year
knudson
pioneer
observ
cancer
world
radic
alter
develop
genom
technolog
enabl
analysi
characteris
thousand
gene
biopsi
materi
includ
importantli
archiv
materi
much
effort
devot
find
gene
signatur
allow
patient
better
wwwthelancetcom
vol
decemb
characteris
especi
relat
probabl
prognosi
respons
treatment
result
suggest
molecular
signatur
inde
predict
respons
therapi
although
earli
claim
may
exagger
seem
like
molecular
profil
stay
max
perutz
wit
birth
molecular
haematolog
public
linu
paul
classic
paper
scienc
describ
sicklecel
diseas
due
small
chang
electr
charg
haemoglobin
vernon
ingram
work
cambridg
show
alter
charg
due
replac
one
aminoacid
chain
anoth
mani
year
molecular
haematolog
domin
field
structur
medicin
carlbertil
laurel
discoveri
antitrypsin
defici
caus
emphysema
stimul
robin
carrel
sequenc
antitrypsin
identif
mutat
respons
failur
proteinas
inhibitor
protect
lung
reveal
posit
activ
site
confer
specif
inhibitor
neutrophil
elastas
similar
sequenc
present
anoth
plasma
proteas
inhibitor
antithrombin
comparison
two
site
suggest
specif
inhibit
depend
one
aminoacid
case
boy
pittsburgh
fatal
haemorrhag
disord
whose
plasma
contain
electrophoret
variant
antitrypsin
act
inhibitor
coagul
provid
confirm
carrel
predict
establish
methionin
activ
site
mutat
arginin
chang
specif
inhibitor
antineutrophil
proteas
antithrombina
dramat
natur
experi
protein
engin
second
exampl
robin
carrel
group
also
relat
antitrypsin
david
loma
respiratori
doctor
propos
intracellular
aggreg
mutat
molecul
hepatocyt
reduc
secret
antitrypsin
suggest
aggreg
molecul
could
seen
electron
microscopi
figur
caus
hepatocyt
injuri
cirrhosi
structur
studi
show
molecular
mechan
respons
process
might
gener
pathogen
mechan
diseas
characteris
intracellular
inclus
bodi
graphic
shown
case
studi
famili
doctor
upstat
new
york
insist
autopsi
patient
age
year
die
atyp
dementia
neuropatholog
examin
nearbi
syracus
reveal
intraneur
inclus
bodi
partial
sequenc
ident
newli
identifi
serpinneuroserpinspecif
neuron
came
light
patient
member
famili
inherit
mendelian
domin
trait
result
onset
encephalopathi
dementia
age
year
similar
intraneur
inclus
antitrypsin
defici
led
collabor
worker
syracus
carrel
loma
show
everi
step
pathway
loma
observ
mutat
antitrypsin
faith
reproduc
abnorm
neuroserpin
thu
intracellular
polymeris
result
cellular
attrit
hepatocyt
lead
cirrhosi
neuron
lead
encephalopathi
dementia
grant
sutherland
studi
fragil
x
syndrom
commonest
caus
famili
mental
retard
discov
disord
associ
expans
heredit
trinucleotid
repeat
sequenc
ccg
give
rise
fragil
site
x
chromosom
transpir
sever
diseas
characteris
triplet
repeat
agc
repeat
associ
neurolog
disord
myoton
dystrophi
neurodegen
disord
huntington
diseas
triplet
repeat
cag
code
glutamin
diseas
strike
characterist
explan
mendelian
genet
phenomenon
anticip
genet
diseas
becom
increasingli
sever
present
earlier
success
gener
genom
analysi
provid
explan
success
gener
number
repeat
expand
correl
invers
sever
age
present
counterpart
human
disord
found
anim
max
perutz
earlier
notic
altern
posit
neg
charg
aminoacid
haemoglobin
parasit
worm
ascari
lumbricoid
conclud
aminoacid
chain
potenti
form
polar
zipper
learn
triplet
repeat
expans
characterist
huntington
diseas
offer
eleg
explan
expans
triplet
repeat
creat
long
glutamin
chain
could
action
polar
zipper
account
format
intracellular
aggreg
characteris
diseas
figur
amyloid
protein
misfold
mark
pepi
investig
calciumdepend
bind
protein
serum
amyloid
p
compon
socal
bind
amyloid
fibril
led
develop
diagnost
radionuclid
test
amyloid
sap
scintigraphi
allow
quantif
amyloid
load
mana
requir
evalu
monitor
treatmentwhich
turn
led
referr
accumul
patient
variou
form
amyloidosi
rare
famili
case
amyloidosi
inform
excel
exampl
famili
autosom
domin
diseas
sequenc
show
amyloid
fibril
deriv
mutat
enzym
lysozym
lysozym
use
small
molecular
weight
kda
protein
model
variou
experiment
studi
notabl
late
david
phillip
second
protein
first
enzym
complet
threedimension
structur
solv
studi
extens
respect
protein
fold
especi
chri
dobson
depart
chemistri
cambridg
whose
studi
mechan
lysozym
fibrillogenesi
provid
basi
understand
diseas
brought
protein
misfold
like
contemporari
familiar
notion
proteinprotein
interact
could
pathogen
immunecomplex
diseas
anticip
import
gener
paradigm
abnorm
protein
fold
would
becom
prusin
discoveri
prionsinfecti
protein
agent
produc
effect
induc
conform
chang
equival
normal
brain
protein
subsequ
protein
aggregationi
dramat
exampl
immunolog
gener
complement
system
particular
revolutionis
advanc
protein
chemistri
one
case
chang
think
physiolog
system
background
peter
lachmann
done
research
substanc
known
conglutinogen
activ
factor
kaf
action
need
conglutininth
first
describ
mammalian
plasma
lectin
peculiar
bovidaeto
react
start
point
patient
boston
call
tj
recurr
bacteri
infect
chester
alper
colleagu
establish
abnorm
breakdown
vivo
respons
persist
infect
conclud
experi
addit
serum
fresh
plasma
purifi
restor
complement
function
reduc
breakdown
might
inborn
defici
protein
necessari
stabil
vivo
vitro
natur
defici
complement
activ
might
altern
pathway
complement
activ
inde
suspect
idea
fallen
disreput
discoveri
rare
peopl
anim
defici
whose
serum
still
support
complement
activ
gramneg
bacteria
peter
lachmann
collabor
chester
alper
show
complet
absenc
kaf
deplet
normal
sera
kaf
pattern
activ
ident
tj
could
produc
reprint
refer
permiss
elsevi
propos
term
altern
pathway
complement
normal
tick
slow
rate
kept
control
kaf
defici
deplet
kaf
led
uncontrol
activ
pathway
kaf
renam
inactiv
factor
later
shown
doug
fearon
physiolog
activ
altern
pathway
act
prevent
complement
regul
factor
anoth
inhibitor
factor
h
exert
effect
tj
exist
intricaci
altern
pathway
would
almost
certainli
emerg
investig
anoth
extraordinari
clinic
syndrom
time
due
singl
gene
defect
studi
sera
rare
form
glomerulonephr
histologist
term
membranoprolif
glomerulonephr
mpgn
reveal
form
complement
activ
involv
classic
pathway
associ
circul
factor
caus
breakdown
ad
normal
human
serum
socal
nephrit
factor
nef
later
shown
nef
autoantibodi
block
action
altern
pathway
inhibitor
factor
h
normal
labil
enzym
break
stabilis
therebi
lead
excess
consumpt
ident
system
complement
activ
also
found
patient
rare
disord
partial
lipodystrophi
pld
known
associ
mpgn
clinic
associ
indic
peculiar
form
autoimmun
seem
predispos
mpgn
pld
underli
mechan
particularli
adipocyt
destruct
obscur
late
genet
technolog
shown
mice
knockout
anoth
complement
regulatori
factor
factor
h
physiolog
inhibit
altern
pathway
develop
mpgn
establish
beyond
doubt
primari
causal
role
unrestrain
altern
pathway
activ
disord
adipocyt
clue
came
late
discoveri
enzym
adipocyt
name
adipsin
ident
altern
pathway
complement
factor
factor
elev
concentr
factor
potenti
altern
pathway
activ
rais
possibl
appropri
circumst
activ
altern
pathway
enhanc
nef
might
caus
lysi
fat
cell
peter
mathieson
abl
show
could
inde
take
place
vitro
find
complement
factor
adipocyt
gener
signific
earliest
unequivoc
indic
adipocyt
storag
cell
excess
fat
might
hitherto
unsuspect
biolog
function
lead
leptin
stori
leptin
first
hormon
whose
role
demonstr
control
appetit
begin
discoveri
genet
obes
mous
obob
mous
pioneer
parabiot
experi
link
obob
mice
normal
miceestablish
normal
mice
provid
factor
revers
obes
obob
mice
clearli
obob
mous
lack
factor
present
blood
normal
mice
control
food
intak
fat
mass
friedman
colleagu
identifi
obob
mous
defici
leptin
hormon
secret
fat
cell
act
hypothalamu
earli
hope
leptin
might
valu
treat
obes
dash
find
normal
circumst
obes
human
be
high
plasma
leptin
concentr
malnourish
individu
low
plasma
leptin
level
reflect
circumst
adipocyt
mass
stephen
orahilli
group
first
identifi
human
equival
obob
mous
seri
consanguin
famili
leptin
total
absent
children
morbid
obes
characteris
uncontrol
hyperphagia
dramat
revers
administr
recombin
leptina
remark
albeit
extrem
demonstr
central
control
mechan
satieti
understand
obes
figur
unexpect
twist
stori
leptin
turn
immunoregulatori
hormon
obob
mice
leptindefici
children
impair
tcell
function
figur
pose
question
whether
immun
defici
associ
starvat
origin
whole
part
adipocyt
loss
consequ
hypoleptinaemia
sinc
clear
adipocyt
secret
variou
cytokin
convers
question
extent
untoward
consequ
gross
excess
adipocyt
tissu
includ
cancer
cardiovascular
diseas
might
explain
subtl
adipocyt
depend
pertub
immunoinflammatori
system
area
research
attract
great
interest
experiment
model
clinic
plasma
exchang
autoimmun
frank
dixon
establish
paradigm
pathogenet
mechan
glomerulonephritisnam
two
underli
immunolog
mechan
first
mediat
autoantibodi
especi
glomerular
basement
membran
gbm
second
due
accumul
glomerulu
circul
immun
complex
two
process
readili
distinguish
immunofluoresc
examin
renal
biopsi
sampl
antibodi
gbm
usual
associ
devast
diseas
goodpastur
syndrom
lung
basement
membran
also
damag
caus
lifethreaten
pulmonari
haemorrhag
kidney
function
rapidli
lost
due
sever
prolif
nephriti
rapidli
progress
glomerulonephr
rpgn
reason
circul
autoantibodi
inde
caus
diseas
intervent
aim
reduc
generationimmunosuppressioncombin
plasma
exchang
remov
antibodi
allevi
diseas
surpris
find
antibodi
product
perman
arrest
patient
fewer
week
figur
taken
mani
year
research
immunoregulatori
mechan
begin
throw
light
might
brought
past
decad
convinc
characteris
regulatori
cell
whose
engag
shift
balanc
activatori
regulatori
cell
could
explain
termin
autoimmun
respons
subject
regulatori
cell
major
area
immunolog
researchand
devis
immunolog
intervent
specif
promot
gener
immunolog
control
system
suppress
unwant
immun
respons
includ
immun
respons
transplant
organ
major
goal
modern
immunolog
success
antigbm
syndrom
led
consider
put
diseas
patient
critic
ill
easier
evalu
first
myasthenia
gravi
suspect
although
proven
due
autoantibodi
acetylcholin
receptor
achr
collabor
john
newsomdavi
abl
show
dramat
respons
plasma
exchang
patient
refractori
diseas
figur
later
shown
correl
fall
circul
antiachr
antibodi
concentr
experi
establish
circul
antibodi
achr
inde
respons
neuromuscular
dysfunct
characterist
myasthenia
gravi
man
show
use
plasmaexchang
determin
whether
circul
autoantibodi
pathogen
antigbm
nephriti
characterist
present
rpgn
patient
rpgn
antigbm
antibodi
immunofluoresc
renal
biopsi
sampl
usual
show
evid
accumul
immun
reactant
kidney
antigenantibodi
complex
detect
circul
find
led
use
term
pauciimmun
patient
therefor
match
dixon
experiment
model
rational
treat
group
patient
immunosuppress
drug
plasma
exchang
flimsi
surprisingli
respons
regimen
plasma
exchang
cytotox
drug
better
patient
antigbm
diseas
might
explan
circul
autoantibodi
whose
signific
immedi
appreci
detect
plasma
categori
rpgn
patient
confusingli
direct
intracellular
antigen
neutrophilsantineutrophil
cytoplasm
antibodi
anca
later
associ
wegen
granulomatosi
due
cours
princip
target
anca
identifi
myeloperoxidas
antiproteinas
anca
test
prove
great
diagnost
practic
valu
monitor
therapi
work
show
antibodi
would
activ
neutrophil
make
potenti
capabl
enhanc
tissu
damag
howev
still
clear
whether
anca
caus
consequ
nephriti
vascul
resolut
requir
technolog
late
centuri
gene
myeloperoxidas
mpo
knock
mous
knockout
mice
immunis
mous
myeloperoxidas
made
antibodi
antibodi
transfer
normal
mice
mpo
white
cell
necrotis
vascul
nephriti
produc
thu
requir
three
decad
research
move
bedsid
bench
man
mous
elucid
scientif
basi
empir
therapeut
discoveri
new
paradigm
renovascular
immunopatholog
establish
name
autoantibodi
activ
neutrophil
central
pathogenet
mechan
import
group
disord
monoclon
immunoglobulin
first
recognis
patient
myeloma
much
knowledg
immunoglobulin
structur
function
genet
come
studi
myeloma
protein
kunkel
putnam
other
earlier
exampl
knowledg
transfer
bedsid
laboratori
work
also
provid
basi
technolog
devis
milstein
kohler
product
monoclon
antibodi
mice
fusion
lymphocyt
myeloma
cell
mid
great
interest
potenti
use
monoclon
antibodi
man
particular
use
control
transplant
reject
treatment
immunolog
malign
lymphoma
major
limit
treatment
chronic
diseas
human
be
would
mount
antimurin
immun
respons
breakthrough
product
greg
winter
mrc
laboratori
molecular
biolog
humanis
antibodi
combin
site
mous
rat
antibodi
genet
transplant
onto
framework
human
antibodi
could
repeatedli
use
man
greatli
reduc
chanc
evok
immun
respons
potenti
approach
shown
one
patient
autoimmun
diseas
whose
condit
seemingli
cure
administr
immunosuppress
monoclon
antibodi
patient
retir
doctor
histori
refractori
vascul
unrespons
variou
convent
cytotox
immunosuppress
drug
given
combin
monoclon
antibodi
base
protocol
devis
induct
immun
toler
mice
herman
waldmann
sustain
remiss
follow
vasculit
relaps
die
year
later
colon
cancer
treatment
arrest
autoimmun
respons
campath
advanc
trial
import
autoimmun
diseas
multipl
sclerosi
collabor
alastair
compston
herman
waldmann
even
unexpect
dramat
benefit
discov
maini
feldmann
effect
monoclon
antibodi
tumour
necrosi
factor
work
owe
origin
find
high
level
synovi
tissu
rheumatoid
arthriti
although
potenti
interf
immunolog
driven
inflamm
inhibit
defin
mediat
object
research
decad
anticip
scale
benefit
found
clinic
maini
colleagu
confirm
mani
other
antibodybas
therapi
subtend
multibilliondollar
industri
mani
drug
advanc
clinic
trial
approv
use
man
condit
rang
lymphoma
angina
late
small
group
us
move
royal
postgradu
medic
school
clinic
school
addenbrook
hospit
cambridg
driven
convict
need
closer
partnership
clinic
basic
biomed
research
especi
molecular
cell
biolog
consider
degre
pioneer
mrc
laboratori
molecular
biolog
addenbrook
site
sought
link
academ
servic
develop
addenbrook
hospit
provid
hospit
care
substanti
popul
east
anglia
prioriti
develop
cultur
clinic
research
key
provis
advanc
medic
technolog
includ
particular
imag
technolog
goal
promot
populationbas
medic
research
help
nh
establish
institut
public
health
incorpor
mrc
biostatist
unit
univers
depart
nh
public
health
group
pleas
develop
epidemiolog
gap
narrow
intens
investig
hospit
patient
studi
largescal
popul
medic
technolog
use
techniqu
autom
biochemistri
genom
technolog
imag
endoscopi
allow
research
undertaken
popul
long
ago
could
done
small
group
patient
clinic
investig
unit
wellworkedup
patient
replac
wellworkedup
commun
construct
laboratori
enabl
clinic
basic
biomed
scientist
work
sidebysid
brainimag
centr
clinic
research
facil
revitalis
clinic
research
clinic
research
unit
major
pharmaceut
compani
laboratori
emerg
disciplin
genom
epidemiolog
paramount
import
cultur
chang
addenbrook
nh
trust
reflect
least
plan
develop
conjunct
mrc
univers
biomed
campu
aim
improv
clinic
servic
provid
outstand
facil
teach
research
maximis
wealthgener
opportun
nh
offer
theme
health
wealth
gener
given
momentum
nation
public
govern
accept
report
academi
medic
scienc
biotechnolog
innov
growth
team
chair
respect
prof
john
bell
sir
david
cucksey
academi
report
emphasis
need
term
experiment
medicin
detail
studi
patient
stateoftheart
techniqu
encompass
latest
imag
modal
appropri
biochem
genom
proteom
technolog
biotechnolog
pharmaceut
sector
experiment
medicin
facilit
target
choic
acceler
drug
develop
pharmaceut
clinic
academ
commun
concern
infrastructur
type
medic
research
urgent
need
strengthen
past
year
manyinclud
influenti
leader
western
medicinehav
express
concern
clinic
investig
imperil
speci
may
surpris
greater
spirit
optim
consid
research
tool
power
hitherto
inconceiv
within
week
sar
outbreak
respons
coronaviru
identifi
fulli
sequenc
compar
compar
period
year
achiev
hiv
brain
imag
capabl
elucid
neuron
basi
normal
cognit
function
revolutionis
research
psychiatri
gene
array
technolog
creat
new
paradigm
cancer
therapi
clinic
academ
feel
threaten
clinic
research
inher
difficult
scientif
train
teach
us
formul
hypothes
set
experi
test
rigor
control
variabl
minimis
confound
factor
human
genet
heterogen
ill
mani
confound
variabl
realiti
much
clinic
research
start
point
seri
observ
astut
clinic
observ
notic
someth
except
usual
technolog
har
first
time
clinic
set
member
peerreview
research
committe
often
observ
destruct
critic
clinic
research
applic
usual
clinic
peer
seemingli
infinit
capac
identifi
problem
hapless
wouldb
research
control
dismiss
worthwhil
exploratori
propos
fish
expedit
basic
biomed
scientist
wit
deliber
forgiven
conclud
respect
clinic
research
methodolog
randomis
control
trial
research
art
solubl
medawar
gift
clinic
investig
flee
laboratori
control
experi
exampl
experi
mice
genet
constitut
order
laboratori
diseaseori
research
increasingli
becom
domain
nonmed
qualifi
research
workerswho
requir
shorter
period
univers
educ
devot
fulli
medic
research
without
distract
clinic
practic
clinic
research
worker
may
seen
expens
wholli
engag
address
problem
difficult
messi
fund
agenc
face
choic
rigor
propos
basic
biomed
scienc
versu
research
patient
behav
predict
may
forget
reallif
messi
problem
need
solut
much
present
analysi
seemingli
complex
problem
reveal
conceptu
rel
simpl
explan
genet
mutat
produc
function
chang
enzymeth
singl
gene
disord
led
garrod
classic
descript
inborn
error
metabol
satisfyingli
approach
often
elucid
normal
biolog
function
new
target
treatment
approach
much
common
diseas
diseas
maladapt
genet
constitut
relat
uneasili
chang
environ
us
exist
exampl
obes
diabet
high
blood
pressur
allergi
autoimmun
combin
individu
small
effect
mani
gene
basi
suscept
shall
use
exampl
insulindepend
diabet
diseas
caus
autoimmun
destruct
islet
cell
earli
hope
predisposit
disord
attribut
fairli
small
set
hla
gene
soon
dash
john
todd
natur
paper
elucid
small
contribut
one
gene
code
public
involv
peopl
centr
author
includ
geneticist
mice
men
immunologist
comput
biologist
specialist
statist
geneticist
support
programm
grant
cost
million
problem
complex
pose
except
challeng
biolog
complex
address
lead
univers
titl
system
biolog
integr
biolog
comput
biolog
princip
methodolog
paul
nurs
harveian
orat
great
idea
biolog
discuss
way
complex
molecular
interact
cell
might
transform
logic
inform
structur
process
familiar
disciplin
mathemat
physic
data
gener
unpreced
scale
techniqu
gene
array
variou
omic
turn
drive
develop
new
statist
comput
methodolog
also
vast
larg
untap
dataset
patient
record
due
cours
ad
output
initi
genet
epidemiolog
substanti
resourc
extens
collabor
longterm
commit
particular
remov
cultur
barrier
fund
mechan
discourag
interdisciplinari
interinstitut
activ
requir
leav
doctor
scientist
respons
iscentrestag
medic
qualifi
research
worker
one
outstand
advantag
system
univers
educ
teach
human
biolog
effect
medic
school
need
better
present
futur
gener
medic
student
concern
tendenc
teach
research
becom
distinct
activ
research
increasingli
undertaken
purposebuilt
laboratori
entri
restrict
least
anim
terrorist
medic
student
byandlarg
except
gift
reason
expect
contact
best
research
medic
school
nearli
half
centuri
ago
competit
pressur
research
research
assess
exercis
mean
mani
univers
staff
especi
wholli
fund
research
grant
believ
afford
spend
time
teach
sever
uk
medic
school
develop
mbphd
programm
provid
except
student
earli
opportun
engag
research
constraint
profession
train
occur
clear
cambridg
programm
start
major
graduat
commit
academ
career
better
prepar
address
complex
issu
ahead
remain
optimist
uk
govern
commit
substanti
invest
scienc
base
next
decad
medic
scienc
one
countri
great
academ
strength
power
research
intens
pharmaceut
biotechnolog
healthcar
industri
importantli
role
nh
medic
research
recognis
govern
endors
academi
medic
scienc
biotechnolog
innov
growth
team
report
set
clinic
research
collabor
great
intern
interest
must
leav
last
word
distinguish
predecessor
clifford
allbutt
regiu
professor
physic
quot
harveian
orat
padua
medicin
long
degrad
disguis
prove
lineag
mother
natur
scienc
truth
say
hippocr
know
natur
man
one
must
know
natur
thing
